Company Description
ATHX (NASDAQ: ATHX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
ATHX stock has declined 99.5% over the past year.
This page provides a comprehensive overview of ATHX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ATHX (ATHX) stock. Over the past 12 months, the stock has lost 99.5%.
Latest News
ATHX has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, clinical trial, offering, management, conferences. View all ATHX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ATHX Company Profile & Sector Positioning
ATHX (ATHX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.